NEVVI Medicare utilization intelligence

← back

KUCINSKI, JUSTINDO NPI 1689000697 Clinician

Hematology-Oncology · SALISBURY, MD

Specialty Hematology-Oncology — from billed Medicare claims
Trained WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE — medical school, self-reported to CMS
In practice about 14 years since medical school (class of 2012, self-reported to CMS)
Location SALISBURY, MD · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 46 codes billed · 124,202 disclosed services (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026
TIDALHEALTH PHYSICIAN NETWORK, INC.
2025–2026
TIDALHEALTH SPECIALTY CARE LLC
2021–2026
PENINSULA REGIONAL MEDICAL CENTER
2019–2020

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2018-09

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J1756 Injection, iron sucrose, 1 mg
J9299 Injection, nivolumab, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9022 Injection, atezolizumab, 10 mg
J0185 Injection, aprepitant, 1 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
80053 Blood test, comprehensive group of blood chemicals
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
96413 Administration of chemotherapy into vein, 1 hour or less
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
85007 Microscopic examination for white blood cells with manual cell count
J2469 Injection, palonosetron hcl, 25 mcg
96375 Injection of additional new drug or substance into vein
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96372 Injection of drug or substance under skin or into muscle
J9045 Injection, carboplatin, 50 mg
J3489 Injection, zoledronic acid, 1 mg
J7030 Infusion, normal saline solution , 1000 cc
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
96374 Injection of drug or substance into vein
96417 Administration of additional new drug or substance into vein, 1 hour or less
96360 Infusion into a vein for hydration, 31-60 minutes
96361 Infusion into a vein for hydration, each additional hour
96523 Irrigation of implanted venous access drug delivery device
J1200 Injection, diphenhydramine hcl, up to 50 mg
J3490 Unclassified drugs
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99497 Advance care planning, first 30 minutes
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
81000 Manual urinalysis test with examination using microscope, non-automated
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96411 Administration of additional new drug or substance into vein using push technique
38222 Biopsy and aspiration of bone marrow sample for diagnosis
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
36430 Transfusion of blood or blood products
99195 Drawing of blood for a medical problem
36591 Collection of blood sample from implanted device

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.